MovDisordV3, PascalFrancis, Corpus, bibRecord, 001230

Microsubthalamotomy : An Immediate Predictor of Long-Term Subthalamic Stimulation Efficacy in Parkinson Disease

Identifieur interne : 001230 ( PascalFrancis/Corpus ); précédent : 001229; suivant : 001231

Microsubthalamotomy : An Immediate Predictor of Long-Term Subthalamic Stimulation Efficacy in Parkinson Disease

Auteurs : David Maltete ; Stéphane Derrey ; Nathalie Chastan ; Bertrand Debono ; Emmanuel Gerardin ; Pierre Freger ; Bruno Mihout ; Jean Francois Menard ; Didier Hannequin

Source :

Movement disorders [ 0885-3185 ] ; 2008.

RBID : Pascal:08-0305155

Descripteurs français

Pascal (Inist)
- Maladie de Parkinson, Pathologie du système nerveux, Long terme, Noyau sousthalamique, Stimulation cérébrale profonde.

English descriptors

KwdEn :
- Deep brain stimulation, Long term, Nervous system diseases, Parkinson disease, Subthalamic nucleus.

Abstract

A microsubthalamotomy (mSTN) effect is commonly described after implantation that improves Parkinson's motor disability and is considered to be an obvious sign of good placement of the definitive electrode within the subthalamic nucleus (STN). There has been no formal study, however, demonstrating whether this mSTN effect can predict the long-term efficacy of STN stimulation in Parkinson Disease. The mSTN effect was defined by the percentage improvement of unified parkinson's disease rating scale (UPDRS III) baseline score assessed the third day morning following STN implantation, after at least a 12 hour withdrawal of dopaminergic treatment and before the programmable pulse generator was switched on. It was assessed in 30 consecutive patients with PD submitted for STN stimulation. Multiple stepwise regression analysis showed that mSTN effect (P = 0.005) and global mean intensity of stimulation (P = 0.004) were accurate independent predictors of the 6-month postoperative UPDRS III motor score improvement in the off-drug/on-stimulation condition.

Notice en format standard (ISO 2709)

Pour connaître la documentation sur le format Inist Standard.

A01	`01`	`1`		`@0 0885-3185`
A03		`1`		`@0 Mov. disord.`
A05				`@2 23`
A06				`@2 7`
A08	`01`	`1`	`ENG`	`@1 Microsubthalamotomy : An Immediate Predictor of Long-Term Subthalamic Stimulation Efficacy in Parkinson Disease`
A11	`01`	`1`		`@1 MALTETE (David)`
A11	`02`	`1`		`@1 DERREY (Stéphane)`
A11	`03`	`1`		`@1 CHASTAN (Nathalie)`
A11	`04`	`1`		`@1 DEBONO (Bertrand)`
A11	`05`	`1`		`@1 GERARDIN (Emmanuel)`
A11	`06`	`1`		`@1 FREGER (Pierre)`
A11	`07`	`1`		`@1 MIHOUT (Bruno)`
A11	`08`	`1`		`@1 FRANCOIS MENARD (Jean)`
A11	`09`	`1`		`@1 HANNEQUIN (Didier)`
A14	`01`			`@1 Department of Neurology, Rouen University Hospital @2 Rouen @3 FRA @Z 1 aut. @Z 7 aut. @Z 9 aut.`
A14	`02`			`@1 INSERM U614, Rouen Faculty of Medicine Rouen @3 FRA @Z 1 aut. @Z 9 aut.`
A14	`03`			`@1 Department of Neurosurgery, Rouen University Hospital @2 Rouen @3 FRA @Z 2 aut. @Z 4 aut. @Z 6 aut.`
A14	`04`			`@1 Laboratory of Neurophysiology, Rouen University Hospital @2 Rouen @3 FRA @Z 3 aut.`
A14	`05`			`@1 Department of Radiology, Rouen University Hospital @2 Rouen @3 FRA @Z 5 aut.`
A14	`06`			`@1 Department of Biostatistics, Rouen University Hospital @2 Rouen @3 FRA @Z 8 aut.`
A20				`@1 1047-1050`
A21				`@1 2008`
A23	`01`			`@0 ENG`
A43	`01`			`@1 INIST @2 20953 @5 354000200276040200`
A44				`@0 0000 @1 © 2008 INIST-CNRS. All rights reserved.`
A45				`@0 21 ref.`
A47	`01`	`1`		`@0 08-0305155`
A60				`@1 P @3 CC`
A61				`@0 A`
A64	`01`	`1`		`@0 Movement disorders`
A66	`01`			`@0 USA`
C01	`01`		`ENG`	@0 A microsubthalamotomy (mSTN) effect is commonly described after implantation that improves Parkinson's motor disability and is considered to be an obvious sign of good placement of the definitive electrode within the subthalamic nucleus (STN). There has been no formal study, however, demonstrating whether this mSTN effect can predict the long-term efficacy of STN stimulation in Parkinson Disease. The mSTN effect was defined by the percentage improvement of unified parkinson's disease rating scale (UPDRS III) baseline score assessed the third day morning following STN implantation, after at least a 12 hour withdrawal of dopaminergic treatment and before the programmable pulse generator was switched on. It was assessed in 30 consecutive patients with PD submitted for STN stimulation. Multiple stepwise regression analysis showed that mSTN effect (P = 0.005) and global mean intensity of stimulation (P = 0.004) were accurate independent predictors of the 6-month postoperative UPDRS III motor score improvement in the off-drug/on-stimulation condition.
C02	`01`	`X`		`@0 002B17`
C02	`02`	`X`		`@0 002B17G`
C03	`01`	`X`	`FRE`	`@0 Maladie de Parkinson @2 NM @5 01`
C03	`01`	`X`	`ENG`	`@0 Parkinson disease @2 NM @5 01`
C03	`01`	`X`	`SPA`	`@0 Parkinson enfermedad @2 NM @5 01`
C03	`02`	`X`	`FRE`	`@0 Pathologie du système nerveux @5 02`
C03	`02`	`X`	`ENG`	`@0 Nervous system diseases @5 02`
C03	`02`	`X`	`SPA`	`@0 Sistema nervioso patología @5 02`
C03	`03`	`X`	`FRE`	`@0 Long terme @5 09`
C03	`03`	`X`	`ENG`	`@0 Long term @5 09`
C03	`03`	`X`	`SPA`	`@0 Largo plazo @5 09`
C03	`04`	`X`	`FRE`	`@0 Noyau sousthalamique @5 10`
C03	`04`	`X`	`ENG`	`@0 Subthalamic nucleus @5 10`
C03	`04`	`X`	`SPA`	`@0 Núcleo subtalámico @5 10`
C03	`05`	`X`	`FRE`	`@0 Stimulation cérébrale profonde @4 CD @5 96`
C03	`05`	`X`	`ENG`	`@0 Deep brain stimulation @4 CD @5 96`
C07	`01`	`X`	`FRE`	`@0 Pathologie de l'encéphale @5 37`
C07	`01`	`X`	`ENG`	`@0 Cerebral disorder @5 37`
C07	`01`	`X`	`SPA`	`@0 Encéfalo patología @5 37`
C07	`02`	`X`	`FRE`	`@0 Syndrome extrapyramidal @5 38`
C07	`02`	`X`	`ENG`	`@0 Extrapyramidal syndrome @5 38`
C07	`02`	`X`	`SPA`	`@0 Extrapiramidal síndrome @5 38`
C07	`03`	`X`	`FRE`	`@0 Maladie dégénérative @5 39`
C07	`03`	`X`	`ENG`	`@0 Degenerative disease @5 39`
C07	`03`	`X`	`SPA`	`@0 Enfermedad degenerativa @5 39`
C07	`04`	`X`	`FRE`	`@0 Pathologie du système nerveux central @5 40`
C07	`04`	`X`	`ENG`	`@0 Central nervous system disease @5 40`
C07	`04`	`X`	`SPA`	`@0 Sistema nervosio central patología @5 40`
C07	`05`	`X`	`FRE`	`@0 Encéphale @5 42`
C07	`05`	`X`	`ENG`	`@0 Encephalon @5 42`
C07	`05`	`X`	`SPA`	`@0 Encéfalo @5 42`
C07	`06`	`X`	`FRE`	`@0 Système nerveux central @5 43`
C07	`06`	`X`	`ENG`	`@0 Central nervous system @5 43`
C07	`06`	`X`	`SPA`	`@0 Sistema nervioso central @5 43`
N21				`@1 189`
N44	`01`			`@1 OTO`
N82				`@1 OTO`

Format Inist (serveur)

NO :	PASCAL 08-0305155 INIST
ET :	Microsubthalamotomy : An Immediate Predictor of Long-Term Subthalamic Stimulation Efficacy in Parkinson Disease
AU :	MALTETE (David); DERREY (Stéphane); CHASTAN (Nathalie); DEBONO (Bertrand); GERARDIN (Emmanuel); FREGER (Pierre); MIHOUT (Bruno); FRANCOIS MENARD (Jean); HANNEQUIN (Didier)
AF :	Department of Neurology, Rouen University Hospital/Rouen/France (1 aut., 7 aut., 9 aut.); INSERM U614, Rouen Faculty of Medicine Rouen/France (1 aut., 9 aut.); Department of Neurosurgery, Rouen University Hospital/Rouen/France (2 aut., 4 aut., 6 aut.); Laboratory of Neurophysiology, Rouen University Hospital/Rouen/France (3 aut.); Department of Radiology, Rouen University Hospital/Rouen/France (5 aut.); Department of Biostatistics, Rouen University Hospital/Rouen/France (8 aut.)
DT :	Publication en série; Courte communication, note brève; Niveau analytique
SO :	Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 2008; Vol. 23; No. 7; Pp. 1047-1050; Bibl. 21 ref.
LA :	Anglais
EA :	A microsubthalamotomy (mSTN) effect is commonly described after implantation that improves Parkinson's motor disability and is considered to be an obvious sign of good placement of the definitive electrode within the subthalamic nucleus (STN). There has been no formal study, however, demonstrating whether this mSTN effect can predict the long-term efficacy of STN stimulation in Parkinson Disease. The mSTN effect was defined by the percentage improvement of unified parkinson's disease rating scale (UPDRS III) baseline score assessed the third day morning following STN implantation, after at least a 12 hour withdrawal of dopaminergic treatment and before the programmable pulse generator was switched on. It was assessed in 30 consecutive patients with PD submitted for STN stimulation. Multiple stepwise regression analysis showed that mSTN effect (P = 0.005) and global mean intensity of stimulation (P = 0.004) were accurate independent predictors of the 6-month postoperative UPDRS III motor score improvement in the off-drug/on-stimulation condition.
CC :	002B17; 002B17G
FD :	Maladie de Parkinson; Pathologie du système nerveux; Long terme; Noyau sousthalamique; Stimulation cérébrale profonde
FG :	Pathologie de l'encéphale; Syndrome extrapyramidal; Maladie dégénérative; Pathologie du système nerveux central; Encéphale; Système nerveux central
ED :	Parkinson disease; Nervous system diseases; Long term; Subthalamic nucleus; Deep brain stimulation
EG :	Cerebral disorder; Extrapyramidal syndrome; Degenerative disease; Central nervous system disease; Encephalon; Central nervous system
SD :	Parkinson enfermedad; Sistema nervioso patología; Largo plazo; Núcleo subtalámico
LO :	INIST-20953.354000200276040200
ID :	08-0305155

Links to Exploration step

Pascal:08-0305155

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Microsubthalamotomy : An Immediate Predictor of Long-Term Subthalamic Stimulation Efficacy in Parkinson Disease</title>
<author><name sortKey="Maltete, David" sort="Maltete, David" uniqKey="Maltete D" first="David" last="Maltete">David Maltete</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Neurology, Rouen University Hospital</s1>
<s2>Rouen</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="02"><s1>INSERM U614, Rouen Faculty of Medicine Rouen</s1>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Derrey, Stephane" sort="Derrey, Stephane" uniqKey="Derrey S" first="Stéphane" last="Derrey">Stéphane Derrey</name>
<affiliation><inist:fA14 i1="03"><s1>Department of Neurosurgery, Rouen University Hospital</s1>
<s2>Rouen</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Chastan, Nathalie" sort="Chastan, Nathalie" uniqKey="Chastan N" first="Nathalie" last="Chastan">Nathalie Chastan</name>
<affiliation><inist:fA14 i1="04"><s1>Laboratory of Neurophysiology, Rouen University Hospital</s1>
<s2>Rouen</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Debono, Bertrand" sort="Debono, Bertrand" uniqKey="Debono B" first="Bertrand" last="Debono">Bertrand Debono</name>
<affiliation><inist:fA14 i1="03"><s1>Department of Neurosurgery, Rouen University Hospital</s1>
<s2>Rouen</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Gerardin, Emmanuel" sort="Gerardin, Emmanuel" uniqKey="Gerardin E" first="Emmanuel" last="Gerardin">Emmanuel Gerardin</name>
<affiliation><inist:fA14 i1="05"><s1>Department of Radiology, Rouen University Hospital</s1>
<s2>Rouen</s2>
<s3>FRA</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Freger, Pierre" sort="Freger, Pierre" uniqKey="Freger P" first="Pierre" last="Freger">Pierre Freger</name>
<affiliation><inist:fA14 i1="03"><s1>Department of Neurosurgery, Rouen University Hospital</s1>
<s2>Rouen</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Mihout, Bruno" sort="Mihout, Bruno" uniqKey="Mihout B" first="Bruno" last="Mihout">Bruno Mihout</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Neurology, Rouen University Hospital</s1>
<s2>Rouen</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Francois Menard, Jean" sort="Francois Menard, Jean" uniqKey="Francois Menard J" first="Jean" last="Francois Menard">Jean Francois Menard</name>
<affiliation><inist:fA14 i1="06"><s1>Department of Biostatistics, Rouen University Hospital</s1>
<s2>Rouen</s2>
<s3>FRA</s3>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Hannequin, Didier" sort="Hannequin, Didier" uniqKey="Hannequin D" first="Didier" last="Hannequin">Didier Hannequin</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Neurology, Rouen University Hospital</s1>
<s2>Rouen</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="02"><s1>INSERM U614, Rouen Faculty of Medicine Rouen</s1>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">08-0305155</idno>
<date when="2008">2008</date>
<idno type="stanalyst">PASCAL 08-0305155 INIST</idno>
<idno type="RBID">Pascal:08-0305155</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">001230</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Microsubthalamotomy : An Immediate Predictor of Long-Term Subthalamic Stimulation Efficacy in Parkinson Disease</title>
<author><name sortKey="Maltete, David" sort="Maltete, David" uniqKey="Maltete D" first="David" last="Maltete">David Maltete</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Neurology, Rouen University Hospital</s1>
<s2>Rouen</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="02"><s1>INSERM U614, Rouen Faculty of Medicine Rouen</s1>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Derrey, Stephane" sort="Derrey, Stephane" uniqKey="Derrey S" first="Stéphane" last="Derrey">Stéphane Derrey</name>
<affiliation><inist:fA14 i1="03"><s1>Department of Neurosurgery, Rouen University Hospital</s1>
<s2>Rouen</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Chastan, Nathalie" sort="Chastan, Nathalie" uniqKey="Chastan N" first="Nathalie" last="Chastan">Nathalie Chastan</name>
<affiliation><inist:fA14 i1="04"><s1>Laboratory of Neurophysiology, Rouen University Hospital</s1>
<s2>Rouen</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Debono, Bertrand" sort="Debono, Bertrand" uniqKey="Debono B" first="Bertrand" last="Debono">Bertrand Debono</name>
<affiliation><inist:fA14 i1="03"><s1>Department of Neurosurgery, Rouen University Hospital</s1>
<s2>Rouen</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Gerardin, Emmanuel" sort="Gerardin, Emmanuel" uniqKey="Gerardin E" first="Emmanuel" last="Gerardin">Emmanuel Gerardin</name>
<affiliation><inist:fA14 i1="05"><s1>Department of Radiology, Rouen University Hospital</s1>
<s2>Rouen</s2>
<s3>FRA</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Freger, Pierre" sort="Freger, Pierre" uniqKey="Freger P" first="Pierre" last="Freger">Pierre Freger</name>
<affiliation><inist:fA14 i1="03"><s1>Department of Neurosurgery, Rouen University Hospital</s1>
<s2>Rouen</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Mihout, Bruno" sort="Mihout, Bruno" uniqKey="Mihout B" first="Bruno" last="Mihout">Bruno Mihout</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Neurology, Rouen University Hospital</s1>
<s2>Rouen</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Francois Menard, Jean" sort="Francois Menard, Jean" uniqKey="Francois Menard J" first="Jean" last="Francois Menard">Jean Francois Menard</name>
<affiliation><inist:fA14 i1="06"><s1>Department of Biostatistics, Rouen University Hospital</s1>
<s2>Rouen</s2>
<s3>FRA</s3>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Hannequin, Didier" sort="Hannequin, Didier" uniqKey="Hannequin D" first="Didier" last="Hannequin">Didier Hannequin</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Neurology, Rouen University Hospital</s1>
<s2>Rouen</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="02"><s1>INSERM U614, Rouen Faculty of Medicine Rouen</s1>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="2008">2008</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Deep brain stimulation</term>
<term>Long term</term>
<term>Nervous system diseases</term>
<term>Parkinson disease</term>
<term>Subthalamic nucleus</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Maladie de Parkinson</term>
<term>Pathologie du   système nerveux</term>
<term>Long terme</term>
<term>Noyau sousthalamique</term>
<term>Stimulation cérébrale profonde</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">A microsubthalamotomy (mSTN) effect is commonly described after implantation that improves Parkinson's motor disability and is considered to be an obvious sign of good placement of the definitive electrode within the subthalamic nucleus (STN). There has been no formal study, however, demonstrating whether this mSTN effect can predict the long-term efficacy of STN stimulation in Parkinson Disease. The mSTN effect was defined by the percentage improvement of unified parkinson's disease rating scale (UPDRS III) baseline score assessed the third day morning following STN implantation, after at least a 12 hour withdrawal of dopaminergic treatment and before the programmable pulse generator was switched on. It was assessed in 30 consecutive patients with PD submitted for STN stimulation. Multiple stepwise regression analysis showed that mSTN effect (P = 0.005) and global mean intensity of stimulation (P = 0.004) were accurate independent predictors of the 6-month postoperative UPDRS III motor score improvement in the off-drug/on-stimulation condition.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0885-3185</s0>
</fA01>
<fA03 i2="1"><s0>Mov. disord.</s0>
</fA03>
<fA05><s2>23</s2>
</fA05>
<fA06><s2>7</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Microsubthalamotomy : An Immediate Predictor of Long-Term Subthalamic Stimulation Efficacy in Parkinson Disease</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>MALTETE (David)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>DERREY (Stéphane)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>CHASTAN (Nathalie)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>DEBONO (Bertrand)</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>GERARDIN (Emmanuel)</s1>
</fA11>
<fA11 i1="06" i2="1"><s1>FREGER (Pierre)</s1>
</fA11>
<fA11 i1="07" i2="1"><s1>MIHOUT (Bruno)</s1>
</fA11>
<fA11 i1="08" i2="1"><s1>FRANCOIS MENARD (Jean)</s1>
</fA11>
<fA11 i1="09" i2="1"><s1>HANNEQUIN (Didier)</s1>
</fA11>
<fA14 i1="01"><s1>Department of Neurology, Rouen University Hospital</s1>
<s2>Rouen</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>9 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>INSERM U614, Rouen Faculty of Medicine Rouen</s1>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>9 aut.</sZ>
</fA14>
<fA14 i1="03"><s1>Department of Neurosurgery, Rouen University Hospital</s1>
<s2>Rouen</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
</fA14>
<fA14 i1="04"><s1>Laboratory of Neurophysiology, Rouen University Hospital</s1>
<s2>Rouen</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
</fA14>
<fA14 i1="05"><s1>Department of Radiology, Rouen University Hospital</s1>
<s2>Rouen</s2>
<s3>FRA</s3>
<sZ>5 aut.</sZ>
</fA14>
<fA14 i1="06"><s1>Department of Biostatistics, Rouen University Hospital</s1>
<s2>Rouen</s2>
<s3>FRA</s3>
<sZ>8 aut.</sZ>
</fA14>
<fA20><s1>1047-1050</s1>
</fA20>
<fA21><s1>2008</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>20953</s2>
<s5>354000200276040200</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2008 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>21 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>08-0305155</s0>
</fA47>
<fA60><s1>P</s1>
<s3>CC</s3>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Movement disorders</s0>
</fA64>
<fA66 i1="01"><s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>A microsubthalamotomy (mSTN) effect is commonly described after implantation that improves Parkinson's motor disability and is considered to be an obvious sign of good placement of the definitive electrode within the subthalamic nucleus (STN). There has been no formal study, however, demonstrating whether this mSTN effect can predict the long-term efficacy of STN stimulation in Parkinson Disease. The mSTN effect was defined by the percentage improvement of unified parkinson's disease rating scale (UPDRS III) baseline score assessed the third day morning following STN implantation, after at least a 12 hour withdrawal of dopaminergic treatment and before the programmable pulse generator was switched on. It was assessed in 30 consecutive patients with PD submitted for STN stimulation. Multiple stepwise regression analysis showed that mSTN effect (P = 0.005) and global mean intensity of stimulation (P = 0.004) were accurate independent predictors of the 6-month postoperative UPDRS III motor score improvement in the off-drug/on-stimulation condition.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B17</s0>
</fC02>
<fC02 i1="02" i2="X"><s0>002B17G</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Maladie de Parkinson</s0>
<s2>NM</s2>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Parkinson disease</s0>
<s2>NM</s2>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Parkinson enfermedad</s0>
<s2>NM</s2>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Pathologie du   système nerveux</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Nervous system diseases</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Sistema nervioso patología</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Long terme</s0>
<s5>09</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Long term</s0>
<s5>09</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Largo plazo</s0>
<s5>09</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Noyau sousthalamique</s0>
<s5>10</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Subthalamic nucleus</s0>
<s5>10</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Núcleo subtalámico</s0>
<s5>10</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Stimulation cérébrale profonde</s0>
<s4>CD</s4>
<s5>96</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Deep brain stimulation</s0>
<s4>CD</s4>
<s5>96</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Pathologie de l'encéphale</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Cerebral disorder</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Encéfalo patología</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Syndrome extrapyramidal</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Extrapyramidal syndrome</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Extrapiramidal síndrome</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Maladie dégénérative</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Degenerative disease</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Enfermedad degenerativa</s0>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Pathologie du   système nerveux central</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Central nervous system disease</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Sistema nervosio central patología</s0>
<s5>40</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE"><s0>Encéphale</s0>
<s5>42</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG"><s0>Encephalon</s0>
<s5>42</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA"><s0>Encéfalo</s0>
<s5>42</s5>
</fC07>
<fC07 i1="06" i2="X" l="FRE"><s0>Système nerveux central</s0>
<s5>43</s5>
</fC07>
<fC07 i1="06" i2="X" l="ENG"><s0>Central nervous system</s0>
<s5>43</s5>
</fC07>
<fC07 i1="06" i2="X" l="SPA"><s0>Sistema nervioso central</s0>
<s5>43</s5>
</fC07>
<fN21><s1>189</s1>
</fN21>
<fN44 i1="01"><s1>OTO</s1>
</fN44>
<fN82><s1>OTO</s1>
</fN82>
</pA>
</standard>
<server><NO>PASCAL 08-0305155 INIST</NO>
<ET>Microsubthalamotomy : An Immediate Predictor of Long-Term Subthalamic Stimulation Efficacy in Parkinson Disease</ET>
<AU>MALTETE (David); DERREY (Stéphane); CHASTAN (Nathalie); DEBONO (Bertrand); GERARDIN (Emmanuel); FREGER (Pierre); MIHOUT (Bruno); FRANCOIS MENARD (Jean); HANNEQUIN (Didier)</AU>
<AF>Department of Neurology, Rouen University Hospital/Rouen/France (1 aut., 7 aut., 9 aut.); INSERM U614, Rouen Faculty of Medicine Rouen/France (1 aut., 9 aut.); Department of Neurosurgery, Rouen University Hospital/Rouen/France (2 aut., 4 aut., 6 aut.); Laboratory of Neurophysiology, Rouen University Hospital/Rouen/France (3 aut.); Department of Radiology, Rouen University Hospital/Rouen/France (5 aut.); Department of Biostatistics, Rouen University Hospital/Rouen/France (8 aut.)</AF>
<DT>Publication en série; Courte communication, note brève; Niveau analytique</DT>
<SO>Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 2008; Vol. 23; No. 7; Pp. 1047-1050; Bibl. 21 ref.</SO>
<LA>Anglais</LA>
<EA>A microsubthalamotomy (mSTN) effect is commonly described after implantation that improves Parkinson's motor disability and is considered to be an obvious sign of good placement of the definitive electrode within the subthalamic nucleus (STN). There has been no formal study, however, demonstrating whether this mSTN effect can predict the long-term efficacy of STN stimulation in Parkinson Disease. The mSTN effect was defined by the percentage improvement of unified parkinson's disease rating scale (UPDRS III) baseline score assessed the third day morning following STN implantation, after at least a 12 hour withdrawal of dopaminergic treatment and before the programmable pulse generator was switched on. It was assessed in 30 consecutive patients with PD submitted for STN stimulation. Multiple stepwise regression analysis showed that mSTN effect (P = 0.005) and global mean intensity of stimulation (P = 0.004) were accurate independent predictors of the 6-month postoperative UPDRS III motor score improvement in the off-drug/on-stimulation condition.</EA>
<CC>002B17; 002B17G</CC>
<FD>Maladie de Parkinson; Pathologie du   système nerveux; Long terme; Noyau sousthalamique; Stimulation cérébrale profonde</FD>
<FG>Pathologie de l'encéphale; Syndrome extrapyramidal; Maladie dégénérative; Pathologie du   système nerveux central; Encéphale; Système nerveux central</FG>
<ED>Parkinson disease; Nervous system diseases; Long term; Subthalamic nucleus; Deep brain stimulation</ED>
<EG>Cerebral disorder; Extrapyramidal syndrome; Degenerative disease; Central nervous system disease; Encephalon; Central nervous system</EG>
<SD>Parkinson enfermedad; Sistema nervioso patología; Largo plazo; Núcleo subtalámico</SD>
<LO>INIST-20953.354000200276040200</LO>
<ID>08-0305155</ID>
</server>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001230 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 001230 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    PascalFrancis
   |étape=   Corpus
   |type=    RBID
   |clé=     Pascal:08-0305155
   |texte=   Microsubthalamotomy : An Immediate Predictor of Long-Term Subthalamic Stimulation Efficacy in Parkinson Disease
}}

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

	Movement Disorders (revue)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Movement Disorders (revue)

Microsubthalamotomy : An Immediate Predictor of Long-Term Subthalamic Stimulation Efficacy in Parkinson Disease

Microsubthalamotomy : An Immediate Predictor of Long-Term Subthalamic Stimulation Efficacy in Parkinson Disease

Source :

Descripteurs français

English descriptors

Abstract

Notice en format standard (ISO 2709)

Format Inist (serveur)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri